Independent research-peptide intelligence
Check the
certificate.
Then choose
the vendor.
We grade research peptides by published evidence and we score vendors by public certificates of analysis. Every claim links to its source.
No paid placement. No sponsored ranks. Read our methodology.
Rank 01 · transparency index
Helix Research
9499.1%
Purity
2–4d
Ships
✓
3P-COA
- 8
- Peptide profiles, each one cited
- 5
- Vendors with a public COA archive
- 4
- Regulatory regions in the tracker
- 6
- Linked primary sources
Every vendor score links to a public COA. If we cannot see the certificate, we do not score the vendor.
We rank vendors on proof,
not on price.
One scorecard applies to every vendor. We check four things: an independent laboratory, a COA that matches your lot number, a disclosed analytical method, and clear country of origin. A vendor earns a high score when you can check its claims yourself. We publish the certificate we used. You can open it.
The thesis
A vendor earns trust by making itself auditable. If you can't verify a claim, it's marketing.
We anchor every score to publicly verifiable certificates of analysis — batch-matched, third-party, method-disclosed. No affiliate deals, no paid placement, no exceptions.
Three evidence grades.
No hype.
Emerging
Early preclinical work. Limited data, or no independent replication.
Moderate
A large preclinical body. Some human data.
Established
Strong human clinical evidence.
Each profile lists its sources with a PubMed or ClinicalTrials.gov link. You can read the study yourself.
Recovery & Healing
BPC-157
A synthetic pentadecapeptide studied heavily in preclinical tissue-repair models.
Recovery & Healing
TB-500
An actin-regulating peptide fragment studied in cell-migration and repair models.
Metabolic
Semaglutide
A GLP-1 receptor agonist with extensive human clinical trial data for metabolic endpoints.
Growth Hormone
Tesamorelin
A GHRH analog with FDA-approved clinical indications and strong human data.
Growth Hormone
Ipamorelin
A selective GH secretagogue studied for its clean receptor profile in preclinical models.
Same molecule.
Different rules.
We track the status of each compound by region, and we link every row to the regulator that published it.
NowThe FDA Pharmacy Compounding Advisory Committee reviewed BPC-157, TB-500, KPV and MOTS-c on 23 July 2026. We track the outcome.
- Approved
Semaglutide
The FDA approves semaglutide as a prescription medicine. The FDA declared the shortage resolved on 21 February 2025. Enforcement discretion for 503A pharmacies ended on 22 April 2025 and for 503B facilities on 22 May 2025. On 30 April 2026 the FDA proposed to exclude semaglutide, tirzepatide and liraglutide from the 503B Bulks List.
- Approved
Tesamorelin
The FDA approves tesamorelin for one clinical indication. Any other use falls outside the approval.
- Research-only
BPC-157
The FDA placed BPC-157 in Category 2 in 2023. A 503A pharmacy cannot compound it. The Pharmacy Compounding Advisory Committee reviewed it on 23 July 2026 for the 503A Bulks List. WADA names BPC-157 under S0 and prohibits it at all times.
- Research-only
TB-500
No FDA approval. The Pharmacy Compounding Advisory Committee reviewed TB-500 on 23 July 2026 for wound healing. WADA prohibits it in sport.
- Research-only
Ipamorelin
No FDA approval. The FDA placed ipamorelin acetate in Category 2. WADA prohibits it in sport.
Explore by goal.
Recovery & Healing
Tissue repair & recovery
The most-researched category, centered on tendon, ligament, and soft-tissue repair models — overwhelmingly preclinical.
Open guide →
Metabolic
Metabolic & body composition
Anchored by GLP-1 science with genuine human trials — and the clearest case for clinical rather than research channels.
Open guide →
Longevity & Anti-Aging
Longevity & anti-aging
Telomere, circadian, and dermal-remodeling research. Compelling mechanisms, thin independent replication.
Open guide →Tools · lab arithmetic
Do the arithmetic
before you handle the vial.
Use the Reconstitution Calculator to find concentration and draw volume. Use the Stack Builder to see the evidence spread across a set of compounds. These tools do laboratory arithmetic. They do not give a dose and they are not medical advice.